Skip to main content
Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
94.12
+0.88 (0.94%)
At close: Jun 26, 2026, 4:00 PM EDT
93.90
-0.22 (-0.23%)
After-hours: Jun 26, 2026, 7:58 PM EDT

Abbott Laboratories Revenue by Segment
Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Medical Devices
22.03B 21.39B 20.76B 20.06B 19.43B 18.99B 18.38B 17.88B
Medical Devices Growth
13.40% 12.65% 12.99% 12.22% 11.40% 12.43% 13.48% 14.90%
Diagnostics
9.06B 8.94B 9.00B 9.16B 9.18B 9.34B 9.36B 9.39B
Diagnostics Growth
-1.29% -4.33% -3.79% -2.48% -3.50% -6.48% -13.05% -21.61%
Nutrition
8.32B 8.45B 8.64B 8.55B 8.49B 8.41B 8.32B 8.33B
Nutrition Growth
-1.99% 0.45% 3.82% 2.69% 2.86% 3.18% 4.90% 8.80%
Established Pharmaceuticals
5.70B 5.54B 5.42B 5.32B 5.23B 5.19B 5.15B 5.11B
Established Pharmaceuticals Growth
9.07% 6.58% 5.32% 4.05% 2.45% 2.53% 1.74% 1.83%
Other
16.00M 17.00M 17.00M 17.00M 16.00M 16.00M 15.00M 15.00M
Other Growth
- 6.25% 13.33% 13.33% 14.29% 14.29% 15.38% 25.00%

Revenue by Geography
Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
International
27.90B 27.20B 26.76B 26.12B 25.70B 25.63B 25.29B 25.18B
International Growth
8.57% 6.15% 5.83% 3.75% 2.98% 3.93% 4.33% 3.93%
United States
17.23B 17.13B 17.08B 16.99B 16.65B 16.32B 15.93B 15.55B
United States Growth
3.53% 4.92% 7.24% 9.27% 8.30% 5.64% 1.33% -2.83%

Operating Expense Breakdown
Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Selling, General, and Administrative
13.01B 12.33B 12.11B 11.95B 11.80B 11.70B 11.51B 11.34B
Selling, General, and Administrative Growth
10.27% 5.43% 5.18% 5.40% 5.86% 6.83% 2.82% 1.21%
Research and Development
2.99B 2.94B 2.96B 2.90B 2.88B 2.84B 2.80B 2.75B
Research and Development Growth
4.07% 3.45% 5.76% 5.41% 3.79% 3.76% 1.05% -4.24%
Amortization
1.68B 1.68B 1.73B 1.78B 1.83B 1.88B 1.89B 1.92B
Amortization Growth
-7.78% -10.44% -8.92% -7.55% -6.21% -4.48% -4.39% -3.18%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.